Framework Conditions for Health Research and Innovation
The presentation, entitled International Collaboration to Pave the Way for Policy Advice and Enhanced Framework Conditions in Research and Innovation, was delivered by CAAST-Net Plus partner representatives Dr Gatama Gichini of Kenya’s science and education ministry and Mike Kachedwa of Malawi's National Commission for Science & Technology.
Mike Kachedwa - National Commission for Science and Technology, Malawi
"The role of public-private partnerships with local and international companies in promoting innovations in health and medical (‘health’) technologies is an opportunity that should always be explored and nurtured.
"There is a need for development of health technologies and equipment for use in resource limited African settings. A number of mechanisms discussed aim at improving research, innovation and transfer of health technologies. These included the identification of technology development start-up funds to support technology prototype development, transfer and commercialisation; collaborative ventures between clinicians and engineers aimed at identifying health technology needs that could be translated into research and real products for use in resource limited clinical settings; and enabling forums to showcase new and existing products.
"Factors that impede the development of health technologies include: import levies or duties that national governments charge on the importation of all parts required for manufacturing of products; bottlenecks at both national and international levels that still exist in the procedures, guidelines and regulations to pre-qualify, evaluate and register the technologies for use; and political will and capacity across African countries to reshape their policies is still key to creating an enabling environment for development of health technologies.
"Communities in the hard-to-reach areas of Africa have difficulties in accessing health technologies. Deaths can be prevented if essential technologies are used and if clinics and markets in remote areas are appropriately resourced. Much as innovation in the development of technologies is being called for, local stakeholders and the international community must be innovative in implementing equitable, efficient, and scalable programmes that promote access to essential drugs and diagnostics."
*This presentation also appeared in the CAAST-Net Plus Magazine of December 2015.
[Image credit: Flickr, AIDSVaccine]
This content was produced by *Research Africa for CAAST-Net Plus. To report an error, write to firstname.lastname@example.org. To learn more about us, go to www.researchresearch.com/africa.
Disclaimer: CAAST-Net Plus is funded by the European Union’s Seventh Framework Programme for Research and Technological Development (FP7/2007-2013) under grant agreement n0 311806. This document reflects only the authors’ views and the European Union cannot be held liable for any use that may be made of the information contained herein.